Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Kerlone 20mg tablets
0204000G0BBAAAA
|
Kerlone | Betaxolol hydrochloride | Cardiovascular System | No data available |
|
Ketanodur 60mg modified-release tablets
0206010K0BYAAAE
|
Ketanodur | Isosorbide mononitrate | Cardiovascular System | No data available |
|
Ketanserin 20mg tablets
0205080A0AAABAB
|
Ketanserin | Ketanserin | Cardiovascular System | No data available |
|
Ketensin 20mg tablets
0205080A0BCAAAB
|
Ketensin | Ketanserin | Cardiovascular System | No data available |
|
Kinidin 250mg Durules
0203020T0BCAAAB
|
Kinidin Durule | Quinidine bisulfate | Cardiovascular System | No data available |
|
Kogenate Bayer 1,000unit inj vials
0211000I0BDACAH
|
Kogenate | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Kogenate Bayer 2,000unit inj vials
0211000I0BDADAI
|
Kogenate | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Kogenate Bayer 250unit inj vials
0211000I0BDABAF
|
Kogenate | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Kogenate Bayer 3,000unit inj vials
0211000I0BDAEAP
|
Kogenate | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Kogenate Bayer 500unit inj vials
0211000I0BDAAAG
|
Kogenate | Dried factor VIII fraction | Cardiovascular System | No data available |
|
Komil 5mg/40mg tablets
0202040B0BHAAAA
|
Komil | Co-amilofruse (Amiloride hydrochloride/frusemide) | Cardiovascular System | No data available |
|
Labetalol 1.5mg/5ml oral liquid
0204000I0AAANAN
|
Labetalol hydrochloride | Labetalol hydrochloride | Cardiovascular System | No data available |
|
Labetalol 100mg/20ml solution for injection ampoules
0204000I0AAAAAA
|
Labetalol hydrochloride | Labetalol hydrochloride | Cardiovascular System | No data available |
|
Labetalol 100mg/5ml oral liquid
0204000I0AAALAL
|
Labetalol hydrochloride | Labetalol hydrochloride | Cardiovascular System | No data available |
|
Labetalol 10mg/5ml oral liquid
0204000I0AAAMAM
|
Labetalol hydrochloride | Labetalol hydrochloride | Cardiovascular System | No data available |
|
Labetalol 200mg/5ml oral liquid
0204000I0AAAJAJ
|
Labetalol hydrochloride | Labetalol hydrochloride | Cardiovascular System | No data available |
|
Labetalol 25mg/5ml oral liquid
0204000I0AAAKAK
|
Labetalol hydrochloride | Labetalol hydrochloride | Cardiovascular System | No data available |
|
Labetalol 50mg/10ml inj pre-filled syringes
0204000I0AAAPAP
|
Labetalol hydrochloride | Labetalol hydrochloride | Cardiovascular System | No data available |
|
Labetalol 5mg/5ml oral liquid
0204000I0AAARAR
|
Labetalol hydrochloride | Labetalol hydrochloride | Cardiovascular System | No data available |
|
Labetalol 75mg/5ml oral liquid
0204000I0AAAQAQ
|
Labetalol hydrochloride | Labetalol hydrochloride | Cardiovascular System | No data available |
|
Lacidipine 2mg/5ml oral suspension
0206020K0AAADAD
|
Lacidipine | Lacidipine | Cardiovascular System | No data available |
|
Lanoxin 500micrograms/2ml solution for infusion ampoules
0201010F0BBACAC
|
Lanoxin | Digoxin | Cardiovascular System | No data available |
|
Lanoxin Injection Pediatric 100micrograms/1ml inj ampoules
0201010F0BBAGAR
|
Lanoxin | Digoxin | Cardiovascular System | No data available |
|
Lasikal modified-release tablets
0202080K0BBAAAA
|
Lasikal | Furosemide/potassium | Cardiovascular System | No data available |
|
Lasix 20mg tablets
0202020L0BGAGBB
|
Lasix | Furosemide | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.